BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprisi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KLOSTERMANN Stefan REGULA Joerg Thomas SCHAEFER Wolfgang BACAC Marina MOLHOJ Michael NEUMANN (formally JAEGER) Christiane KLEIN Christian AST Oliver IMHOF-JUNG Sabine UMANA Pablo |
| description | The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3608337TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3608337TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3608337TT13</originalsourceid><addsrcrecordid>eNrjZDBz8gwOcHX2dPN0VghRcHb18VFwdA7xDHMM8fRzV3D0C_F0d_VTcPL0cwHxff19XJ1DfVyDeRhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJfLCnsZmBhbGxeUiIoTExagAFSSg4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES</title><source>esp@cenet</source><creator>KLOSTERMANN Stefan ; REGULA Joerg Thomas ; SCHAEFER Wolfgang ; BACAC Marina ; MOLHOJ Michael ; NEUMANN (formally JAEGER) Christiane ; KLEIN Christian ; AST Oliver ; IMHOF-JUNG Sabine ; UMANA Pablo</creator><creatorcontrib>KLOSTERMANN Stefan ; REGULA Joerg Thomas ; SCHAEFER Wolfgang ; BACAC Marina ; MOLHOJ Michael ; NEUMANN (formally JAEGER) Christiane ; KLEIN Christian ; AST Oliver ; IMHOF-JUNG Sabine ; UMANA Pablo</creatorcontrib><description>The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.</description><language>eng ; slv</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240731&DB=EPODOC&CC=SI&NR=3608337T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240731&DB=EPODOC&CC=SI&NR=3608337T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KLOSTERMANN Stefan</creatorcontrib><creatorcontrib>REGULA Joerg Thomas</creatorcontrib><creatorcontrib>SCHAEFER Wolfgang</creatorcontrib><creatorcontrib>BACAC Marina</creatorcontrib><creatorcontrib>MOLHOJ Michael</creatorcontrib><creatorcontrib>NEUMANN (formally JAEGER) Christiane</creatorcontrib><creatorcontrib>KLEIN Christian</creatorcontrib><creatorcontrib>AST Oliver</creatorcontrib><creatorcontrib>IMHOF-JUNG Sabine</creatorcontrib><creatorcontrib>UMANA Pablo</creatorcontrib><title>BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES</title><description>The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBz8gwOcHX2dPN0VghRcHb18VFwdA7xDHMM8fRzV3D0C_F0d_VTcPL0cwHxff19XJ1DfVyDeRhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJfLCnsZmBhbGxeUiIoTExagAFSSg4</recordid><startdate>20240731</startdate><enddate>20240731</enddate><creator>KLOSTERMANN Stefan</creator><creator>REGULA Joerg Thomas</creator><creator>SCHAEFER Wolfgang</creator><creator>BACAC Marina</creator><creator>MOLHOJ Michael</creator><creator>NEUMANN (formally JAEGER) Christiane</creator><creator>KLEIN Christian</creator><creator>AST Oliver</creator><creator>IMHOF-JUNG Sabine</creator><creator>UMANA Pablo</creator><scope>EVB</scope></search><sort><creationdate>20240731</creationdate><title>BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES</title><author>KLOSTERMANN Stefan ; REGULA Joerg Thomas ; SCHAEFER Wolfgang ; BACAC Marina ; MOLHOJ Michael ; NEUMANN (formally JAEGER) Christiane ; KLEIN Christian ; AST Oliver ; IMHOF-JUNG Sabine ; UMANA Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3608337TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KLOSTERMANN Stefan</creatorcontrib><creatorcontrib>REGULA Joerg Thomas</creatorcontrib><creatorcontrib>SCHAEFER Wolfgang</creatorcontrib><creatorcontrib>BACAC Marina</creatorcontrib><creatorcontrib>MOLHOJ Michael</creatorcontrib><creatorcontrib>NEUMANN (formally JAEGER) Christiane</creatorcontrib><creatorcontrib>KLEIN Christian</creatorcontrib><creatorcontrib>AST Oliver</creatorcontrib><creatorcontrib>IMHOF-JUNG Sabine</creatorcontrib><creatorcontrib>UMANA Pablo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KLOSTERMANN Stefan</au><au>REGULA Joerg Thomas</au><au>SCHAEFER Wolfgang</au><au>BACAC Marina</au><au>MOLHOJ Michael</au><au>NEUMANN (formally JAEGER) Christiane</au><au>KLEIN Christian</au><au>AST Oliver</au><au>IMHOF-JUNG Sabine</au><au>UMANA Pablo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES</title><date>2024-07-31</date><risdate>2024</risdate><abstract>The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI3608337TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A26%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KLOSTERMANN%20Stefan&rft.date=2024-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3608337TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |